Eris Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Fatehpur Roshnai, Uttar Pradesh, India, established in 2020.
2020 Fatehpur Roshnai, Uttar Pradesh, India Active
Last Updated:
Access Report
About Eris Pharmaceuticals Limited

Eris Pharmaceuticals Limited, a active public limited company, was established on 02 June 2020 in Fatehpur Roshnai, Uttar Pradesh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U33100UP2020PLC128964. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Inderjeet Singh Negi (Director), Kaushal Kamlesh Shah (Director), Sachin Shah (Director). Past directors included Mohit Vaid, Sripat Vaid, Inderjeet Singh Negi. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Arazi No. 1554, Vill Sachendi, Kalpi Road, Fatehpur Roshnai, Uttar Pradesh, 209304.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33100UP2020PLC128964

  • Registration Number

    128964

  • Incorporation Date

    02 June 2020

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 8 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** %
  • Profit Growth **** -375.00%
  • Ebitda **** -500.00%
  • Net Worth -1900.00%
  • Total Assets -70.83%
Company report

Eris Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Eris Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Eris Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Inderjeet Singh Negi Director 30 Jul 2024 Current
Kaushal Kamlesh Shah Director 30 Jul 2024 Current
Sachin Shah Director 30 Jul 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 30 Jul 2024 Past
Pramod Abcsdd Director 30 Jul 2024 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Director 30 Jul 2024 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Eris Pharmaceuticals.

Eris Pharmaceuticals Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 375% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1900%.

Eris Pharmaceuticals revenue growth over time
Eris Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -70.83%
*******
*******
*******
*******
Profit or Loss
*******
 -375.00%
*******
*******
*******
*******
Net Worth
*******
 -1900.00%
*******
*******
*******
*******
EBITDA
*******
 -500.00%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Eris Pharmaceuticals?

In 2023, Eris Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Eris Pharmaceuticals?

Eris Pharmaceuticals has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Eris Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eris Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Eris Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Eris Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Director Appointment

    Inderjeet Singh Negi was appointed as a Director was appointed as a Director on 30 Jul 2024 & has been associated with this company since 1 year 6 months . was recorded as a recent event.

  • Director Appointment

    Kaushal Kamlesh Shah was appointed as a Director was appointed as a Director on 30 Jul 2024 & has been associated with this company since 1 year 6 months . was recorded as a recent event.

  • Director Appointment

    Sachin Shah was appointed as a Director was appointed as a Director on 30 Jul 2024 & has been associated with this company since 1 year 6 months . was recorded as a recent event.

  • Balance Sheet

    Eris Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was recorded as a recent event.

  • Company Incorporation

    Eris Pharmaceuticals Limited was registered on 02 Jun 2020 with Roc Kanpur & aged 5 years 8 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Eris Pharmaceuticals Limited?

The CIN of Eris Pharmaceuticals Limited is U33100UP2020PLC128964.

Where is Eris Pharmaceuticals Limited headquartered?

Eris Pharmaceuticals Limited is headquartered at Arazi No. 1554, Vill Sachendi, Kalpi Road, Fatehpur Roshnai, Uttar Pradesh, 209304.

When was Eris Pharmaceuticals Limited incorporated?

Eris Pharmaceuticals Limited was incorporated on 02 June 2020.

Who are the current directors of Eris Pharmaceuticals Limited?

The current directors of Eris Pharmaceuticals Limited are

What is the primary industry of Eris Pharmaceuticals Limited?

The primary industry of Eris Pharmaceuticals Limited is Trade.

Is Eris Pharmaceuticals Limited a listed company?

Eris Pharmaceuticals Limited is unlisted.

What is the capital structure of Eris Pharmaceuticals Limited?

The authorized capital of Eris Pharmaceuticals Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Eris Pharmaceuticals Limited?

The compliance status of Eris Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available